Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'
Ann Rheum Dis
.
2023 Nov;82(11):e223.
doi: 10.1136/annrheumdis-2021-220938.
Epub 2021 Jul 5.
Authors
Weijie Wang
1
,
Yung-Heng Lee
2
3
4
,
James Cheng Chung Wei
5
6
7
Affiliations
1
Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
2
Department of senior services industry management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
3
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
4
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
5
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan jccwei@gmail.com.
6
Department of Allergy, Immunology & RheumatologyTaiwan, Chung Shan Medical University Hospital, Taichung, Taiwan.
7
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
PMID:
34226191
DOI:
10.1136/annrheumdis-2021-220938
No abstract available
Keywords:
ankylosing; arthritis; epidemiology; spondylitis.
Publication types
Randomized Controlled Trial
Letter
Comment
MeSH terms
Humans
Spondylarthritis* / drug therapy
Spondylitis, Ankylosing*